Rituximab
Also known as Rituxan (us), Reditux (india)
A monoclonal antibody used in lymphomas, leukaemia and some autoimmune diseases, given by infusion.
United States
$2,736
per month
India
$118
per month
You save
$2,61896% cheaper in India
3.2K US scripts/yr$8.5M potential annual savings$8.9M US spend/yr
Compare the price
US price$91per month
India price$425per month
You save-$334-366% less
Based on 1 vial per month. US $91.19 vs India $425.21 per vial.
Total over 1 periodSave -$334$91 → $425
The bigger picture
Rituximab is filled about 3.2K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$8.9M
If sourced from India
$381.7K
Potential annual savings
$8.5M
−96%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.